Inogen (INGN) Enterprise Value Growth (5y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Inogen | 165.85 Mn | 71.44 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.54% |
| Dec 31, 2025 | 14.60% |
| Sep 30, 2025 | 13.34% |
| Jun 30, 2025 | 10.57% |
| Mar 31, 2025 | 10.07% |
| Dec 31, 2024 | 10.36% |
| Sep 30, 2024 | 5.38% |
| Jun 30, 2024 | -5.67% |
| Mar 31, 2024 | -11.89% |
| Dec 31, 2023 | 8.58% |
| Sep 30, 2023 | 31.95% |
| Jun 30, 2023 | 3.98% |
| Mar 31, 2023 | 3.51% |
| Dec 31, 2022 | -21.67% |
| Sep 30, 2022 | -21.01% |
| Jun 30, 2022 | -29.47% |
| Mar 31, 2022 | -15.90% |
| Dec 31, 2021 | -16.61% |
| Sep 30, 2021 | -17.74% |
| Jun 30, 2021 | -20.57% |
| Mar 31, 2021 | -23.03% |
| Dec 31, 2020 | -25.82% |
| Sep 30, 2020 | -29.78% |
| Jun 30, 2020 | -26.51% |
| Mar 31, 2020 | -27.81% |
| Dec 31, 2019 | -25.02% |
| Sep 30, 2019 | -23.16% |
| Jun 30, 2019 | -2.21% |
| Mar 31, 2019 | -2.78% |
| Dec 31, 2018 | -31.37% |
| Sep 30, 2018 | -75.30% |
| Jun 30, 2018 | -64.97% |
| Mar 31, 2018 | -19.86% |
| Dec 31, 2017 | -23.04% |